Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 11238096

Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2001 Mar 15
First author
Haddad E

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Haddad E
      type
      Author
    2. name
      Paczesny S
      type
      Author
    3. name
      Leblond V
      type
      Author
    4. name
      Seigneurin JM
      type
      Author
    5. name
      Stern M
      type
      Author
    6. name
      Achkar A
      type
      Author
    7. name
      Bauwens M
      type
      Author
    8. name
      Delwail V
      type
      Author
    9. name
      Debray D
      type
      Author
    10. name
      Duvoux C
      type
      Author
    11. name
      Hubert P
      type
      Author
    12. name
      Hurault de Ligny B
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Haddad E
      type
      Author
    2. name
      Paczesny S
      type
      Author
    3. name
      Leblond V
      type
      Author
    4. name
      Seigneurin JM
      type
      Author
    5. name
      Stern M
      type
      Author
    6. name
      Achkar A
      type
      Author
    7. name
      Bauwens M
      type
      Author
    8. name
      Delwail V
      type
      Author
    9. name
      Debray D
      type
      Author
    10. name
      Duvoux C
      type
      Author
    11. name
      Hubert P
      type
      Author
    12. name
      Hurault de Ligny B
      type
      Author
    bibliography ids
    1. nci-bib-c18f60a6d3b60d6baa9d41d3
    book metadata
    content sha256
    efde5c68d408518703090473d2ba3153e478b67becb0296d51c00a431f765f84
    document type
    citation
    dois
    1. 10.1182/blood.v97.6.1590
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:11238096
    immutable id
    pubmed:11238096@efde5c68d408518703090473d2ba3153e478b67becb0296d51c00a431f765f84
    journal
    abbreviation
    Blood
    issn electronic
    Source null
    issn print
    0006-4971
    issue
    6
    name
    Blood
    nlm unique id
    7603509
    pages
    1590-7
    volume
    97
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      11238096
      provenance
      batch id
      30d2cd7affbbb92b6784
      provider
      NCBI PubMed ESummary
      record sha256
      99a5320795ffc18b0b5fbb32346e0944a13111a6f6984188da663b1553e1887e
      response sha256
      ae7ed930f8b43c9e34eeae02f278f33f49c15777b81f742392c120eb64949120
      retrieved at
      2026-09-09T23:45:39.779418+00:00
      publication date
      display
      2001 Mar 15
      precision
      day
      year
      2001
      publication types
      1. Clinical Trial
      2. Clinical Trial, Phase I
      3. Clinical Trial, Phase II
      4. Journal Article
      5. Multicenter Study
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/11238096/
      title
      Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial.

      Preserved source evidence · Independent clinical review pending · Not medical advice